MSMuhammad Aiman Shahzad

Muhammad Aiman Shahzad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhammad Aiman Shahzad has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Saqib Mahmood

    Department of Allied Health Sciences, University of Health Sciences, Lahore, Pakistan

    2 shared publications
  • Abdul Nasir

    Medical Research Center, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    1 shared publication
  • Andrew H. Crosby

    RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Barrack Road, Exeter, Devon, EX2 5DW, UK

    1 shared publication
  • Emma L. Baple

    RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Barrack Road, Exeter, Devon, EX2 5DW, UK

    1 shared publication
  • Gaurav V. Harlalka

    RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Barrack Road, Exeter, Devon, EX2 5DW, UK

    1 shared publication
  • Ilaria D’aTri

    RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Barrack Road, Exeter, Devon, EX2 5DW, UK

    1 shared publication

Latest Publications

  • Chromosomal region 1q24.1 is associated with increased risk of schizophrenia in Pakistani population

    by Warda Fatima, Sabeen Riaz, Muhammad Aiman Shahzad, Zara Naz, Saqib Mahmood, Shahida Hasnain


  • Tyrosinase (TYR) gene sequencing and literature review reveals recurrent mutations and multiple population founder gene mutations as causative of oculocutaneous albinism (OCA) in Pakistani families

    by Muhammad Shakil, Gaurav V. Harlalka, Shamshad Ali, Siying Lin, Ilaria D’aTri, Shabbir Hussain, Abdul Nasir, Muhammad Aiman Shahzad, Muhammad Ikram Ullah, Jay E. Self, et al.

    To investigate eight previously unreported Pakistani families with genetically undefined OCA for mutations in TYR. Sanger sequencing of TYR has been performed in eight families with OCA phenotype. Mutation analysis was performed to establish the pathogenic role of novel mutation. Bioinformatics analysis was performed to predict the structural and functional impacts on protein due to the mutation. In this study, we identified six likely pathogenic variants of TYR (c.272 G>A, c.308 G>A, c.346C>T, c.715 C>T, c.832 C>T and c.1255 G>A), including one novel variant (c.308 G>A; p.Cys103Tyr), segregating as appropriate in each family. Cys103 lies in the highly conserved region of the tyrosinase enzyme, and p.Cys103Tyr is predicted to disturb enzymatic function via alteration of the configurational orientation of TYR leading to a more rigid polypeptide structure. We have also reviewed the mutation spectrum of TYR in Pakistani ethnicity. Published data on OCA families proposed that ~40% have been associated with genetic variations in the TYR gene. The mutations reported in this study have now been described with varying frequencies in Pakistani families, including very rare/unique mutations. A literature review of TYR gene mutations in Pakistani populations, combined with our genetic data, identified a number of gene mutations likely to represent regional ancestral founder mutations of relevance to Pakistani populations, in addition to sporadic and recurrent ‘hotspot’ mutations present repeatedly in other regions worldwide.